| 微粒化非诺贝特对原发性高脂血症病人血脂和血液流变性的影响 |
| |
| 引用本文： | 黎明江,胡成林,王晋明,张庆华,许家琍. 微粒化非诺贝特对原发性高脂血症病人血脂和血液流变性的影响[J]. 中国新药与临床杂志, 1999, 18(2) |
| |
| 作者姓名： | 黎明江 胡成林 王晋明 张庆华 许家琍 |
| |
| 作者单位： | 湖北医科大学附属第一医院心内科,湖北武汉430060 |
| |
| 摘 要： | 目的：观察微粒化非诺贝特的降血脂疗效及是否有改善血液流变性的作用。方法：６７例原发性高脂血症病人（男性５１例，女性１６例；年龄５４ａ±ｓ１１ａ）给微粒化非诺贝特２００ｍｇ，ｐｏ，ｑｎ，疗程８ｗｋ。结果：治疗８ｗｋ后血清三酰甘油、总胆固醇、低密度脂蛋白胆固醇和载脂蛋白Ｂ１００显著低于治疗前水平（Ｐ＜０．０１或Ｐ＜０．０５），高密度脂蛋白胆固醇与载脂蛋白ＡＩ升高，（Ｐ＜０．０５）；另外血浆粘度、凝血因子Ｉ、血小板粘附率和血细胞比容较治疗前明显下降（Ｐ＜０．０１或Ｐ＜０．０５）。结论：微粒化非诺贝特能有效降低高血脂，同时明显改善了病人的高粘血症。
|
| 关 键 词： | 非诺贝特；高脂血症；血液流变学 |
Effects of micronised fenofibrate on serum lipid level and hemorheologic changes in patients with primary hyperlipidemia |
| |
| LI Ming-Jiang,HU Cheng-Lin,WANG Jin-Ming,ZHANG Qing-Hua,XU Jia-Li. Effects of micronised fenofibrate on serum lipid level and hemorheologic changes in patients with primary hyperlipidemia[J]. Chinese Journal of New Drugs and Clinical Remedies, 1999, 18(2) |
| |
| Authors: | LI Ming-Jiang HU Cheng-Lin WANG Jin-Ming ZHANG Qing-Hua XU Jia-Li |
| |
| Abstract: | AIM: To study the effects of micronised fenofibrate on serum lipid level and hemorheologic changes in patients with primary hyperlipidemia. METHODS: Sixty_seven patients (M 51, F 16; age 54 a±s 11 a) with hyperlipidemia received micronised fenofibrate 200 mg (200 mg/cap), po, qn×8 wk. RESULTS: After 8 wk, total cholesterol, triglyceride, low density lipoprotein cholesterol, and apolipoprotein B 100 levels were decreased (P<0.01 or P<0.05), high density lipoprotein cholesterol and apolipoprotein AI level was increased (P<0.05); plasma viscosity, fibrinogen, platelet adhesion rate , and hematocrit were decreased ( P < 0.01 or P<0.05). CONCLUSION: Micronised fenofibrate is beneficial on adjusting lipid level and blood viscosity. |
| |
| Keywords: | procetofen hyperlipidemia hemorheology |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
